Catalent & Valerius collaborate on development and manufacture of speciality biosimilars

04:02 EDT 16 May 2018 | EPM Magazine

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions, and Valerius Biopharma, a Swiss biopharmaceutical company, are collaborating on the development and manufacture of speciality biosimilars

More From BioPortfolio on "Catalent & Valerius collaborate on development and manufacture of speciality biosimilars"